NASDAQ : ACOR

Acorda Therapeutics, Inc.

$0.661 USD

-$0.21 (-24.02%)

Volume
321.67K
Average Volume
139.88K
Market Capitalization
$821.03K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$24.20
Year Low
$0.61
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.33
Source Headline

Get ACOR Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

ACOR Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

ACOR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2021-06-17 HC Wainwright & Co. Upgrade Neutral Buy
2020-05-06 H.C. Wainwright Maintain Neutral Neutral
2019-10-24 JP Morgan Downgrade Neutral Underweight
2019-08-14 H.C. Wainwright Downgrade Buy Neutral
2019-08-02 Wedbush Maintain Neutral Neutral
2019-08-02 Stifel Maintain Hold Hold
2019-05-23 Wedbush Maintain Neutral Neutral
2018-12-11 Goldman Sachs Downgrade Neutral Sell
2018-10-05 Stifel Nicolaus Maintain Hold Hold
2018-08-23 Cantor Fitzgerald Maintain Neutral Neutral
2018-08-07 Stifel Nicolaus Maintain Hold Hold
2018-01-31 Oppenheimer Maintain Perform Perform
2017-11-16 Raymond James Downgrade Market Perform Underperform
2017-11-16 Stifel Nicolaus Downgrade Buy Hold
2017-11-16 Cantor Fitzgerald Maintain Neutral Neutral
2017-11-09 Oppenheimer Maintain Perform Perform
2017-11-08 H.C. Wainwright Maintain Buy Buy
2017-11-01 Jefferies Maintain Hold Hold
2017-07-11 Jefferies Maintain Hold Hold
2017-03-13 Janney Capital Upgrade Neutral Buy
2017-02-15 Goldman Sachs Upgrade Sell Neutral
2016-12-19 Janney Capital Maintain Neutral Neutral
2016-12-16 Cantor Fitzgerald Maintain Neutral Neutral
2016-03-30 Goldman Sachs Maintain Neutral Neutral
2016-01-06 Aegis Capital Maintain Buy Buy
2015-06-09 Guggenheim Maintain Neutral Neutral
2015-02-13 Citigroup Maintain Neutral Neutral
2015-02-12 MLV & Co. Maintain Buy Buy
2015-01-13 Citigroup Maintain Neutral Neutral
2014-12-05 Goldman Sachs Maintain Neutral Neutral
2014-10-31 FBR Capital Maintain Outperform Outperform
2014-10-31 Citigroup Maintain Neutral Neutral
2014-05-05 Citigroup Maintain Hold Hold
2014-04-17 Canaccord Genuity Maintain Hold Hold
2014-04-14 FBR Capital Upgrade Market Perform Outperform
2014-01-06 Citigroup Downgrade Buy Neutral
2013-11-01 MKM Partners Maintain Neutral Neutral
2013-05-02 MKM Partners Downgrade Neutral Sell
2013-01-08 MKM Partners Downgrade Buy Neutral
2013-01-03 Citigroup Upgrade Neutral Buy
2012-11-05 Aegis Capital Maintain Buy Buy
2012-08-21 Aegis Capital Maintain Buy Buy
2012-05-18 Goldman Sachs Maintain Sell Sell
2012-02-17 Citigroup Maintain Neutral Neutral